Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner

Genome Research

Volumn 22, Issue 11, 2012, Pages 2153-2162

  Gertz, Jason ^a   Reddy, Timothy E ^a,c   Varley, Katherine E ^a   Garabedian, Michael J ^b   Myers, Richard M ^a  

^a HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CARBOXYLIC ACID; ESTROGEN RECEPTOR ALPHA; GENISTEIN; RNA;

ARTICLE; BINDING SITE; BREAST CANCER; CELL TYPE; ENDOMETRIUM CANCER; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; HORMONE BINDING; HUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RIBOSOME; SOYBEAN; UPREGULATION;

BENZHYDRYL COMPOUNDS; BINDING SITES; CELL LINE, TUMOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS, NON-STEROIDAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; GENISTEIN; GENOME, HUMAN; HUMANS; ORGAN SPECIFICITY; PHENOLS; PHYTOESTROGENS; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION, GENETIC; UP-REGULATION;

GLYCINE MAX;

EID: 84868324642     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.135681.111     Document Type: Article

References (60)

1. Adlercreutz H. 1995. Phytoestrogens: Epidemiology and a possible role in cancer protection. Environ Health Perspect (Suppl 7) 103:103-112.
2. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595.
3. Aksglaede L, Sorensen K, Petersen JH, Skakkebaek NE, Juul A. 2009. Recent decline in age at breast development: The Copenhagen Puberty Study. Pediatrics 123: e932-e939.
4. Ardies CM, Dees C. 1998. Xenoestrogens significantly enhance risk for breast cancer during growth and adolescence. Med Hypotheses 50:457-464.
5. Bergeron RM, Thompson TB, Leonard LS, Pluta L, Gaido KW. 1999. Estrogenicity of bisphenol A in a human endometrial carcinoma cell line. Mol Cell Endocrinol 150:179-187.
6. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, et al. 2006. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38:1289-1297.
7. Castro-Rivera E, Wormke M, Safe S. 1999. Estrogen and aryl hydrocarbon responsiveness of ECC-1 endometrial cancer cells. Mol Cell Endocrinol 150:11-21.
8. Chalbos D, Vignon F, Keydar I, Rochefort H. 1982. Estrogens stimulate cell proliferation and induce secretory proteinsin a human breast cancer cell line (T47D). J Clin Endocrinol Metab 55:276-283.
9. Chang EC, Charn TH, Park SH, Helferich WG, Komm B, Katzenellenbogen JA, Katzenellenbogen BS. 2008. Estrogen receptors a and b as determinants of gene expression: Influence of ligand, dose, and chromatin binding. Mol Endocrinol 22:1032-1043.
10. Cheng Y, Wu W, Kumar SA, Yu D, Deng W, Tripic T, King DC, Chen KB, Zhang Y, Drautz D, et al. 2009. Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res 19:2172-2184.
11. Crain DA, Janssen SJ, Edwards TM, Heindel J, Ho SM, Hunt P, Iguchi T, Juul A, McLachlan JA, Schwartz J, et al. 2008. Female reproductive disorders: The roles of endocrine-disrupting compounds and developmental timing. Fertil Steril 90:911-940.
12. Crawford NP, Qian X, Ziogas A, Papageorge AG, Boersma BJ, Walker RC, Lukes L, Rowe WL, Zhang J, Ambs S, et al. 2007. Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet 3: e214. doi:10.1371/journal.pgen.0030214.
13. Du M, Yang X, Hartman JA, Cooke PS, Doerge DR, Ju YH, Helferich WG. 2012. Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice. Carcinogenesis 33:895-901.
14. Findlay GM, Yan L, Procter J, Mieulet V, Lamb RF. 2007. A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling. Biochem J 403:13-20.
15. Firth SM, Ganeshprasad U, Baxter RC. 1998. Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3. J Biol Chem 273:2631-2638.
16. Fontana JA, Nervi C, Shao ZM, Jetten AM. 1992. Retinoid antagonism of estrogen-responsive transforming growth factor a and pS2 gene expression in breast carcinoma cells. Cancer Res 52:3938-3945.
17. Forster C, Makela S, Warri A, Kietz S, Becker D, Hultenby K, Warner M, Gustafsson JA. 2002. Involvement of estrogen receptor b in terminal differentiation of mammary gland epithelium. Proc Natl Acad Sci 99:15578-15583.
18. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS. 2003. Profiling of estrogen up-and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144:4562-4574.
19. Gertz J, Varley KE, Davis NS, Baas BJ, Goryshin IY, Vaidyanathan R, Kuersten S, Myers RM. 2012. Transposase mediated construction of RNA-seq libraries. Genome Res 22:134-141.
20. Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting NP, Dowsett M, Welch AA, Khaw KT, Wareham NJ, et al. 2004. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer riskin European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiol Biomarkers Prev 13:698-708.
21. Hertz GZ, Stormo GD. 1999. Identifying DNA and protein patterns with statistically significant alignments of multiple sequences. Bioinformatics 15:563-577.
22. Hess-Wilson JK, Boldison J, Weaver KE, Knudsen KE. 2006. Xenoestrogen action in breast cancer: Impact on ER-dependent transcription and mitogenesis. Breast Cancer Res Treat 96:279-292.
23. Hess-Wilson JK, Webb SL, Daly HK, Leung YK, Boldison J, Comstock CE, Sartor MA, Ho SM, Knudsen KE. 2007. Unique bisphenol A transcriptome in prostate cancer: Novel effects on ERb expression that correspondto androgen receptor mutationstatus. Environ Health Perspect 115:1646-1653.
24. Hirsch K, Atzmon A, Danilenko M, Levy J, Sharoni Y. 2007. Lycopene and other carotenoids inhibit estrogenic activity of 17b-estradiol and genistein in cancer cells. Breast Cancer Res Treat 104:221-230.
25. Holder CL, Churchwell MI, Doerge DR. 1999. Quantification of soy isoflavones, genistein and daidzein, and conjugates in rat blood using LC/ES-MS. J Agric Food Chem 47:3764-3770.
26. Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS. 2011. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet 43:27-33.
27. Jacobson-Dickman E, Lee MM. 2009. The influence of endocrine disruptors on pubertal timing. Curr Opin Endocrinol Diabetes Obes 16:25-30.
28. Jefferson WN, Padilla-Banks E, Newbold RR. 2007. Disruption of the developing female reproductive system by phytoestrogens: Genistein as an example. Mol Nutr Food Res 51:832-844.
29. Jeng YJ, Kochukov M, Watson CS. 2010. Combinations of physiologic estrogens with xenoestrogens alter calcium and kinase responses, prolactin release, and membrane estrogen receptor trafficking in rat pituitary cells. Environ Health 9:61. doi:10.1186/1476-069X-9-61.
30. Klein KO, Mericq V, Brown-Dawson JM, Larmore KA, Cabezas P, Cortinez A. 1999. Estrogen levels in girls with premature thelarche compared with normal prepubertal girls as determined by an ultrasensitive recombinant cell bioassay. J Pediatr 134:190-192.
31. Kong SL, Li G, Loh SL, Sung WK, Liu ET. 2011. Cellular reprogramming by the conjoint action of ERa, FOXA1, and GATA3 to a ligand-inducible growth state. Mol Syst Biol 7:526. doi:10.1038/msb.2011.59.
32. Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J, Kimbro KS, Eddy EM, Migliaccio S, Snedeker SM, Lubahn DBet al. 1996. Estrogen receptor gene disruption: Molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res 51:159-186; discussion 186-188.
33. Krum SA, Miranda-Carboni GA, Lupien M, Eeckhoute J, Carroll JS, Brown M. 2008. Unique ERa cistromes control cell type-specific gene regulation. Mol Endocrinol 22:2393-2406.
34. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor b. Endocrinology 139:4252-4263.
35. Lamouille S, Derynck R. 2009. Oncogene and tumour suppressor: The two faces of SnoN. EMBO J 28:3459-3460.
36. Lee S, Suk K, Kim IK, Jang IS, Park JW, Johnson VJ, Kwon TK, Choi BJ, Kim SH. 2008. Signaling pathways of bisphenol A-induced apoptosis in hippocampal neuronal cells: Role of calcium-induced reactive oxygen species, mitogen-activated protein kinases, and nuclear factor-kB. J Neurosci Res 86:2932-2942.
37. Liu X, Brutlag DL, Liu JS. 2001. BioProspector: Discovering conserved DNA motifs in upstream regulatory regions of co-expressed genes. Pac Symp Biocomput 2001:127-138.
38. Maffini MV, Rubin BS, Sonnenschein C, Soto AM. 2006. Endocrine disruptors and reproductive health: The case of bisphenol-A. Mol Cell Endocrinol 254-255:179-186.
39. Masuno H, Iwanami J, Kidani T, Sakayama K, Honda K. 2005. Bisphenol A accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci 84:319-327.
40. Molzberger AF, Vollmer G, Hertrampf T, Moller FJ, Kulling S, Diel P. 2011. In utero and postnatal exposure to isoflavones results in a reduced responsivity of the mammary gland towards estradiol. Mol Nutr Food Res 56:399-409.
41. Moore RJ, Hamilton TH. 1964. Estrogen-induced formation of uterine ribosomes. Proc Natl Acad Sci 52:439-446.
42. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56.
43. Niikura H, Sasano H, Kaga K, Sato S, Yajima A. 1996. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium. Hum Pathol 27:282-289.
44. Nikaido Y, Yoshizawa K, Danbara N, Tsujita-Kyutoku M, Yuri T, Uehara N, Tsubura A. 2004. Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reprod Toxicol 18:803-811.
45. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, Newman B, Van Oene M, Cescon D, Greenberg G, et al. 2004. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36:471-475.
46. Peng L, Malloy PJ, Wang J, Feldman D. 2006. Growth inhibitory concentrations of androgens up-regulate insulin-like growth factor binding protein-3 expression via an androgen response element in LNCaP human prostate cancer cells. Endocrinology 147:4599-4607.
47. Reddy TE, Pauli F, Sprouse RO, Neff NF, Newberry KM, Garabedian MJ, Myers RM. 2009. Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res 19:2163-2171.
48. Reimand J, Kull M, Peterson H, Hansen J, Vilo J. 2007. g:Profiler-a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res 35: W193-W200.
49. Routledge EJ, White R, Parker MG, Sumpter JP. 2000. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) a and ERb. J Biol Chem 275:35986-35993.
50. Santiago JL, Martinez A, de la Calle H, Fernandez-Arquero M, Figueredo MA, de la Concha EG, Urcelay E. 2006. Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: A case control study. BMC Med Genet 7:54. doi:10.1186/1471-2350-7-54.
51. Schonfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. 2002. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect 110: A703-A707.
52. Simpson NE, Gertz J, Imberg K, Myers RM, Garabedian MJ. 2012. Research resource: Enhanced genome-wide occupancy of estrogen receptor a by the cochaperone p23 in breast cancer cells. Mol Endocrinol 26:194-202.
53. Singleton DW, Feng Y, Yang J, Puga A, Lee AV, Khan SA. 2006. Gene expression profiling reveals novel regulation by bisphenol-A in estrogen receptor-a-positive human cells. Environ Res 100:86-92.
54. Storey JD, Tibshirani R. 2003. Statistical significance for genomewide studies. Proc Natl Acad Sci 100:9440-9445.
55. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA. 2004. Estrogen receptor b inhibits 17b-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci 101:1566-1571.
56. Weber Lozada K, Keri RA. 2011. Bisphenol A increases mammary cancer risk in two distinct mouse models of breast cancer. Biol Reprod 85:490-497.
57. Welboren WJ, van Driel MA, Janssen-Megens EM, van Heeringen SJ, Sweep FC, Span PN, Stunnenberg HG. 2009. ChIP-Seq of ERa and RNA polymerase II defines genes differentially responding to ligands. EMBO J 28:1418-1428.
58. Woodruff TK, Walker CL. 2008. Fetal and early postnatal environmental exposures and reproductive health effects in the female. Fertil Steril (Suppl) 89: e47-e51.
59. WAF1/CIP1, promotes the proliferationand tumorigenesis ofnasopharyngeal carcinoma.Oncogene doi:10.1038/onc.2011.629.
60. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, et al. 2008. Model-based analysis of ChIP-Seq (MACS). Genome Biol 9: R137. doi:10.1186/gb-2008-9-9-r137.